Stock Analysis:LHC Group (NASDAQ:LHCG) Stock Target Has Been Increased
In a recent report revealed to investors by RBC Capital Markets on 27 November, LHC Group (NASDAQ:LHCG) had its target hiked to $47.00. The firm now has a solid “Sector Perform” rating on shares.
From a total of 4 analysts covering LHC Group (NASDAQ:LHCG) stock, 3 rate it a ”Buy”, 0 a “Sell”, and 1 a ”Hold”. This means that 75% of the ratings are positive. The highest target price is $53 while the lowest target price is $47. The mean of all analyst targets is $50.67 with a 7.15% above today’s ($47.29) stock price. LHC Group was the topic of 5 analyst reports since August 7, 2015 according to the firm StockzIntelligence Inc. Wells Fargo initiated shares on September 1 with “Outperform” rating.
The stock increased 0.53% or $0.25 on November 27, striking $47.29. Approximately 54,914 shares of stock traded hands. LHC Group, Inc. (NASDAQ:LHCG) has risen 38.92% since April 27, 2015 and is uptrending. It has outperformed by 39.82% the S&P500.
LHC Group, Inc. is a holding company. The company has a market cap of $845.32 million. The Firm provides post-acute health care services to patients through its home nursing agencies, community services agencies, hospice agencies and long-term acute care hospitals . It has 27.49 P/E ratio. It operates in three divisions: home services, hospice services and facility services.
According to Zacks Investment Research, “LHC Group provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. They provide home-based services through their home nursing agencies and hospices and facility-based services through their long-term acute care hospitals and outpatient rehabilitation clinics.” Get a free copy of the Zacks research report on LHC Group, Inc. (LHCG)